235 related articles for article (PubMed ID: 15226426)
1. Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy.
McMullen JR; Shioi T; Zhang L; Tarnavski O; Sherwood MC; Dorfman AL; Longnus S; Pende M; Martin KA; Blenis J; Thomas G; Izumo S
Mol Cell Biol; 2004 Jul; 24(14):6231-40. PubMed ID: 15226426
[TBL] [Abstract][Full Text] [Related]
2. S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway.
Pende M; Um SH; Mieulet V; Sticker M; Goss VL; Mestan J; Mueller M; Fumagalli S; Kozma SC; Thomas G
Mol Cell Biol; 2004 Apr; 24(8):3112-24. PubMed ID: 15060135
[TBL] [Abstract][Full Text] [Related]
3. Role of the insulin-like growth factor 1 (IGF1)/phosphoinositide-3-kinase (PI3K) pathway mediating physiological cardiac hypertrophy.
McMullen JR; Izumo S
Novartis Found Symp; 2006; 274():90-111; discussion 111-7, 152-5, 272-6. PubMed ID: 17019808
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of ribosomal S6 kinase 2 shows differential regulation of its kinase activity from that of ribosomal S6 kinase 1.
Phin S; Kupferwasser D; Lam J; Lee-Fruman KK
Biochem J; 2003 Jul; 373(Pt 2):583-91. PubMed ID: 12713446
[TBL] [Abstract][Full Text] [Related]
5. mGluR-dependent long-term depression is associated with increased phosphorylation of S6 and synthesis of elongation factor 1A but remains expressed in S6K-deficient mice.
Antion MD; Hou L; Wong H; Hoeffer CA; Klann E
Mol Cell Biol; 2008 May; 28(9):2996-3007. PubMed ID: 18316404
[TBL] [Abstract][Full Text] [Related]
6. FoxO1 is required for physiological cardiac hypertrophy induced by exercise but not by constitutively active PI3K.
Weeks KL; Tham YK; Yildiz SG; Alexander Y; Donner DG; Kiriazis H; Harmawan CA; Hsu A; Bernardo BC; Matsumoto A; DePinho RA; Abel ED; Woodcock EA; McMullen JR
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1470-H1485. PubMed ID: 33577435
[TBL] [Abstract][Full Text] [Related]
7. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway.
McMullen JR; Shioi T; Huang WY; Zhang L; Tarnavski O; Bisping E; Schinke M; Kong S; Sherwood MC; Brown J; Riggi L; Kang PM; Izumo S
J Biol Chem; 2004 Feb; 279(6):4782-93. PubMed ID: 14597618
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland.
Suh JM; Song JH; Kim DW; Kim H; Chung HK; Hwang JH; Kim JM; Hwang ES; Chung J; Han JH; Cho BY; Ro HK; Shong M
J Biol Chem; 2003 Jun; 278(24):21960-71. PubMed ID: 12668683
[TBL] [Abstract][Full Text] [Related]
9. Regulation of ribosomal S6 kinase 2 by effectors of the phosphoinositide 3-kinase pathway.
Martin KA; Schalm SS; Richardson C; Romanelli A; Keon KL; Blenis J
J Biol Chem; 2001 Mar; 276(11):7884-91. PubMed ID: 11108711
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of coupling factor 6 attenuates exercise-induced physiological cardiac hypertrophy by inhibiting PI3K/Akt signaling in mice.
Sagara S; Osanai T; Itoh T; Izumiyama K; Shibutani S; Hanada K; Yokoyama H; Yamamoto Y; Yokota T; Tomita H; Magota K; Okumura K
J Hypertens; 2012 Apr; 30(4):778-86. PubMed ID: 22306848
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin attenuates load-induced cardiac hypertrophy in mice.
Shioi T; McMullen JR; Tarnavski O; Converso K; Sherwood MC; Manning WJ; Izumo S
Circulation; 2003 Apr; 107(12):1664-70. PubMed ID: 12668503
[TBL] [Abstract][Full Text] [Related]
12. Development of monoclonal antibodies specific to ribosomal protein S6 kinase 2.
Savinska L; Skorokhod O; Klipa O; Gout I; Filonenko V
Hybridoma (Larchmt); 2012 Aug; 31(4):289-94. PubMed ID: 22894784
[TBL] [Abstract][Full Text] [Related]
13. The type 1 insulin-like growth factor receptor (IGF-IR) pathway is mandatory for the follistatin-induced skeletal muscle hypertrophy.
Kalista S; Schakman O; Gilson H; Lause P; Demeulder B; Bertrand L; Pende M; Thissen JP
Endocrinology; 2012 Jan; 153(1):241-53. PubMed ID: 22087027
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy.
McMullen JR; Amirahmadi F; Woodcock EA; Schinke-Braun M; Bouwman RD; Hewitt KA; Mollica JP; Zhang L; Zhang Y; Shioi T; Buerger A; Izumo S; Jay PY; Jennings GL
Proc Natl Acad Sci U S A; 2007 Jan; 104(2):612-7. PubMed ID: 17202264
[TBL] [Abstract][Full Text] [Related]
15. Transduction of growth or mitogenic signals into translational activation of TOP mRNAs is fully reliant on the phosphatidylinositol 3-kinase-mediated pathway but requires neither S6K1 nor rpS6 phosphorylation.
Stolovich M; Tang H; Hornstein E; Levy G; Cohen R; Bae SS; Birnbaum MJ; Meyuhas O
Mol Cell Biol; 2002 Dec; 22(23):8101-13. PubMed ID: 12417714
[TBL] [Abstract][Full Text] [Related]
16. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.
Veilleux A; Houde VP; Bellmann K; Marette A
Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102
[TBL] [Abstract][Full Text] [Related]
17. A limited role for PI(3,4,5)P3 regulation in controlling skeletal muscle mass in response to resistance exercise.
Hamilton DL; Philp A; MacKenzie MG; Baar K
PLoS One; 2010 Jul; 5(7):e11624. PubMed ID: 20661274
[TBL] [Abstract][Full Text] [Related]
18. Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy.
McMullen JR; Shioi T; Zhang L; Tarnavski O; Sherwood MC; Kang PM; Izumo S
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12355-60. PubMed ID: 14507992
[TBL] [Abstract][Full Text] [Related]
19. The IGF1-PI3K-Akt Signaling Pathway in Mediating Exercise-Induced Cardiac Hypertrophy and Protection.
Weeks KL; Bernardo BC; Ooi JYY; Patterson NL; McMullen JR
Adv Exp Med Biol; 2017; 1000():187-210. PubMed ID: 29098623
[TBL] [Abstract][Full Text] [Related]
20. Ribosomal S6 kinase 2 inhibition by a potent C-terminal repressor domain is relieved by mitogen-activated protein-extracellular signal-regulated kinase kinase-regulated phosphorylation.
Martin KA; Schalm SS; Romanelli A; Keon KL; Blenis J
J Biol Chem; 2001 Mar; 276(11):7892-8. PubMed ID: 11108720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
